Find similar content

Source channel @githubtrending · Post #14647 · Apr 30

#javascript#approval_process#cms#crm#ehr#erp#hr#layui#mysql#oa#privileges#redis#skyeye#springboot#springboot2#springcloud_vue#websocket This platform uses Springboot, Layui, UNI-APP, and Ant Design Vue to create a low-code system for intelligent manufacturing. It includes over 30 application modules and more than 50 electronic workflows, covering CRM, ERP, MES, and more. This system streamlines business processes from customer relations to production and after-sales service, improving efficiency and data transparency. It also manages employee operations, providing a comprehensive solution for businesses. The benefits include faster development, reduced redundancy, and enhanced data management, making it ideal for companies seeking digital transformation. https://github.com/dromara/skyeye

Hashtags

#javascript #approval_process #cms #crm #ehr #erp #hr #layui #mysql #oa #privileges #redis #skyeye #springboot #springboot2 #springcloud_vue #websocket

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment